(Q35581749)

English

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

scientific article published on 17 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

0 references

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials (English)

1 reference

Europe PubMed Central

9 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Jacob A Udell

1

0 references

Deepak L. Bhatt

3

object named as

Deepak L Bhatt

1 reference

Europe PubMed Central

9 August 2017

author name string

Matthew A Cavender

2

1 reference

Europe PubMed Central

9 August 2017

Saurav Chatterjee

4

1 reference

Europe PubMed Central

9 August 2017

Michael E Farkouh

5

1 reference

Europe PubMed Central

9 August 2017

Benjamin M Scirica

6

1 reference

Europe PubMed Central

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 March 2015

1 reference

Europe PubMed Central

9 August 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

9 August 2017

3

1 reference

Europe PubMed Central

9 August 2017

5

1 reference

Europe PubMed Central

9 August 2017

356-366

1 reference

Europe PubMed Central

9 August 2017

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of congestive heart failure in type 2 diabetes: an update

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control and heart failure among adult patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance and risk of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood glucose and heart failure in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between glucose abnormalities and heart failure in the population-based Reykjavik study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of therapies for type 2 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal insulin and cardiovascular and other outcomes in dysglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone for diabetes prevention in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nateglinide on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart in diabetes: not only a macrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes Medications and Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjudication of serious heart failure in patients from PROactive

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(15)00044-3

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35581749&oldid=1634718410"